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ABSTRACT
Hops (Humulus lupulus L.) is by far the greatest contributors to the bitter property of beer. Over the past
years, a large body of evidence demonstrated the presence of taste receptors in different locations of the
oral cavity. In addition to the taste buds of the tongue, cells expressing these receptors have been
identiﬁed in olfactory bulbs, respiratory and gastrointestinal tract. In the gut, the attention was mainly
directed to sweet Taste Receptor (T1R) and bitter Taste Receptor (T2R) receptors. In particular, T2R has
shown to modulate secretion of different gut hormones, mainly Glucagon-like Peptide 1 (GLP-1), which
are involved in the regulation of glucose homeostasis and the control of gut motility, thereby increasing
the sense of satiety. Scientiﬁc interest in the activity of bitter taste receptors emerges because of their
wide distribution in the human species and the large range of natural substances that interact with them.
Beer, whose alcohol content is lower than in other common alcoholic beverages, contains a considerable
amount of bitter compounds and current scientiﬁc evidence shows a direct effect of beer compounds on
glucose homeostasis. The purpose of this paper is to review the available literature data in order to
substantiate the novel hypothesis of a possible direct effect of hop-derived bitter compounds on secretion
of GLP-1, through the activation of T2R, with consequent improvement of glucose homeostasis.
Abbreviations: AMPK: AMP-Activated Protein Kinase; DPP IV: Dipeptidyl Peptidase IV; GI: Glycemic Index; GLP-1:
Glucagon-like Peptide 1; HbA1c: Hemoglobin A1c; HPLC-DAD: High-Performance Liquid Chromatography with
Diode-Array Detection; IBU: International Bittering Units; IL-6: Interleukin 6; LDL: Low Density Lipoprotein; MCP-1:
Monocyte Chemoattractant Protein-1; MUFA: Monounsaturated Fatty Acids; PPAR: Peroxisome Proliferator-Acti-
vated Receptor; PUFA: Polyunsaturated Fatty Acid; SNPs: Single Nucleotide Polymorphisms; T1R: Taste Receptor 1;
T2R: Taste Receptor 2; T2DM: Type 2 Diabetes Mellitus; USDA: U.S. Department of Agriculture
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Introduction
Hops (Humulus lupulus L.), a widely used agent in the brew-
ing industry, is the main contributor to the bitter property of
beer (Liu et al. 2015). Therefore, beer is the most important
dietary source of a number of hop-derived substances. The
effects of beer on glucose homeostasis seem to be still contro-
versial (Huang, Wang, and Zhang 2017; Sluik et al. 2017).
Since numerous years, Scientiﬁc Community agrees to state
that a moderate alcohol consumption of wine and beer shows
the strongest positive effects on health, contributing to reduce,
in particular, cardiovascular risk (de Gaetano et al. 2016). In
this context, the known “French Paradox” demonstrated how
abstemious and high-alcohol consumers have a cardiovascular
risk higher than moderate alcohol consumers (Renaud et al.
1992). This association, deﬁned “U relation” and conﬁrmed
by other studies, underlines the beneﬁcial effects of low
alcohol doses on insulin resistance and, at the same time, the
cardioprotective effect of non-alcoholic compounds in drinks,
in particular, polyphenols (Chiva-Blanch et al. 2013).
However, for many years, the interest was focused on wine,
speciﬁcally due to its content in polyphenolic compounds.
Recently, scientiﬁc research is moving towards the focus also
on the effects of a moderate consumption of beer, which
contains sufﬁcient amounts of polyphenols as well, such as ﬂa-
vonoids and phenolic acids (Arranz et al. 2012). This consid-
eration could explain the mechanism of action that makes
beer comparable to wine about the effects on health. Some
clinical trials demonstrated the role of beer consumption in
improving glucose metabolism (Imhof et al. 2009; Shai et al.
2007; Beulens et al. 2008), and suggested that a further mecha-
nism by which moderate alcohol consumption associated with
beer consumption protects against cardio-vascular disease
could be mediated by the effects of beer-derived polyphenols
on glucose homeostasis (Arranz et al. 2012; Chiva-Blanch
et al. 2013). In a very recent meta-analysis, beer consumption
of 20–30 g/day was associated with a signiﬁcant reduction of
the risk of Type 2 Diabetes Mellitus (T2DM) (Huang, Wang,
and Zhang 2017).
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However, the presence in the beer of considerable amounts
of hop-derived bitter compounds (Kao and Wu 2013) might
provide an alternative explanation for the favourable effects of
moderate beer consumption on glucose metabolism. Indeed,
many studies in literature pointed out the co-localization of bit-
ter taste receptors with endocrine cells of gastrointestinal
secreting gut hormones linked with glucose metabolism (Avau
et al. 2015; Andreozzi et al. 2015). Therefore, our attention has
focused on the possible inﬂuence of bittering acids contained in
the beer on the release of the gut hormones involved in the con-
trol of glucose homeostasis. The purpose of this paper is to
summarize the available literature and to provide a scientiﬁc
plausibility to the novel hypothesis that effects of beer on glu-
cose homeostasis regulation could be also derived from the
interaction between hop-derived bitter compounds and bitter
receptors in gastrointestinal tract.
Hop-derived bitter compounds in beer
Beer is a beverage obtained from the fermentation of a must of
water and cereal, to which hops are added. This complex pro-
duction process makes this drink a harmonious container of
nutrients and bioactive compounds. A traditional approach to
chemical composition would describe beer as a drink composed
almost exclusively of water and ethyl alcohol with a modest
amount of carbohydrates, poor in protein and no fat. Alcohol
content in beer is lower than in other common alcoholic bever-
ages (de Gaetano et al. 2016). It could represent an advantage,
because daily consumption of standard drink of beer (330 ml,
according to U.S. Department of Agriculture, USDA) can be
considerate as moderate alcoholic intake. This moderate con-
sumption has positive effects on health, in particular reducing
T2DM risk. Indeed, epidemiological studies showed how mod-
erate alcohol consumption decrease this risk in man (47000
subjects, 36% lower risk) and women (110000 subjects, 58%
lower risk) (Kondo 2004).
Beer nutritional composition has been widely described.
USDA provided a detailed description taking in account all
micro- and macronutrient (USDA 2017) (Table 1). For many
years, public opinion supported the hypothesis that beer was
more caloric than other alcoholic beverages; because of this rea-
son, it was thought to increase body weight. Several studies
showed that this idea was incorrect (H€at€onen et al. 2012).
Cross-sectional and prospective studies, indeed, demonstrated
that beer consumption does not cause signiﬁcant increase in
body mass index and/or waist-to-hip ratio (Kondo 2004).
The addition of hops enriches the beverage of compounds
such as bitter compounds, aldehydes, ketones, higher alcohols,
polyphenols that give all those typical organoleptic characteris-
tics and, above all, a potential bioactivity. Amount of bitter
compounds present in beer is reported in Table 2 and bitter
compounds have identiﬁed and quantiﬁed by an High-Perfor-
mance Liquid Chromatography with Diode-Array Detection
(HPLC-DAD) and Mass Spectrometry protocol (Kao and Wu
2013). It must be considered that, although mammals have an
adversity to bitter compounds due to the association of bitter
taste to toxins, beer bitter compounds are believed responsible
for imparting to beer the refreshing bitter taste well recognized
by the beer consumer in all well brewed brands of beer.
Individually, these nutrients and other compounds are also
present in other foods and beverages, but considering the com-
plex production technology, it could be hypothesized that beer
is not a mere mix of different ingredients but that all compo-
nents undergo changes during the production process and that
they expose their function to human in a synergistic manner.
Hops (Humulus lupulus L.), by far the greatest contributor to
the bitter property of beer, is a plant belonging to the Cannabi-
naceae botanic family. In most Countries, hops producers grow
non-fertilized female plants, because only female, conical, ﬂow-
ers can be used in brewery. Each female ﬂower has a powdered
and yellow substance at the base, called lupulin. The lupulin
contains bitter resins, essential oils, tannins and terpenes. The
brewing and commercial value of hops is due to its amaricating
and ﬂavouring properties (Liu et al. 2015). Total resins repre-
sent the soluble fraction of hops both in methyl alcohol and in
diethyl ether. Based on their solubility in organic solvents, they
are distinguished by ‘soft resins’ and “hard resins”. Soft resins,
soluble in hexane and in parafﬁnic hydrocarbons, include a-
and b-acids; hard resins, which are non-soluble in parafﬁnic
hydrocarbons, include, instead, oxidation products of a- and
Table 1. Nutritional composition of beer (data from USDA 2017).
Mean content
Units Per 100 g
Per standard
drink, 333.3 ml
Nutrient
Water g 91.96 306.4
Energy kcal 43 143.2
Protein g 0.46 1.53
Total lipid (fat) g 0 0
Carbohydrate, by difference g 3.55 11.8
Fiber, total dietary g 0 0
Sugars, total g 0 0
Minerals
Calcium, Ca mg 4 13.3
Iron, Fe mg 0.02 0.06
Magnesium, Mg mg 6 20
Phosphorus, P mg 14 46.6
Potassium, K mg 27 89.9
Sodium, Na mg 4 13.3
Zinc, Zn mg 0.01 0.03
Copper, Cu mg 0.005 0.016
Manganese, Mn mg 0.008 0.026
Selenium, Se mg 0.6 2
Fluoride, F mg 44.2 147.2
Vitamins
Vitamin C, total ascorbic acid mg 0 0
Thiamin mg 0.005 0.016
Riboﬂavin mg 0.025 0.08
Niacin mg 0.513 1.7
Pantothenic acid mg 0.041 0.14
Vitamin B-6 mg 0.046 0.14
Folate, DFE mg 0.6 2
Choline, total mg 10.1 33.6
Vitamin B-12 mg 0.02 0.06
Vitamin A, RAE mg 0 0
Vitamin E (alpha-tocopherol) mg 0 0
Vitamin D IU 0 0
Vitamin K (phylloquinone) mg 0 0
Amino acids
Alanine g 0.012 0.04
Aspartic acid g 0.016 0.05
Glutamic acid g 0.047 0.15
Glycine g 0.013 0.04
Proline g 0.035 0.12
Other
Alcohol, ethyl g 3.9 13
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b-acids. Different chemical structures have been identiﬁed for
both a- acids and b-acids: humulone, co-humulone, ad-humu-
lone, lupulon, co-lupulon, ad-lupulon with their isomers
(Zhang et al. 2004; Taniguchi et al. 2015).
The bitter characteristics of beer, both for the variety of sub-
stances and for their quantity, depend on the diversity, quantity
and hops adding time. Hops varieties are distinguished by aro-
matic and bittering, depending on the relation between aro-
matic and bitter substances. From the amount of resin added, it
will have beers of different International Bittering Units (IBU)
value. In addition, the a- and b-acids are also isomerized dur-
ing the baking of the must, so if the resin is added at the start of
cooking, the percentage of iso-acids increases. This is one of
the most important considerations to be taken into account in
our hypothesis that beer may be related to regulation of glucose
homeostasis.
Hops have characteristic secondary metabolites (unique
hops compounds: a-acids, b-acids and xanthohumol; highly
characteristic hops compounds: a-humulene, b-caryophyllene)
which are transformed during the brewing process into bitter-
ing and ﬂavoring components (Steenackers, De Cooman, and
De Vos 2015). Among essential oils, monoterpene b-myrcene
and the sesquiterpenes a-humulene and b-caryophyllene are
the major compounds responsible for aroma, while only trace
levels of oxygenated and sulfur compounds are also found
(Almaguer et al. 2014). Mono- and sesquiterpenoid-related
alcohols, such as linalool, geraniol, nerolidol, nerol, and terpin-
eol contribute to the hop aroma. A complex mixture of phe-
nolics, such as ﬂavonols (e.g. quercetin), ﬂavan-3-ols (e.g.
catechin), phenolic acids (e.g. ferulic acid), and corresponding
glycosides and polymers, are also present in the beer (Cham-
pagne and Boutry 2017). Whilst a and b-acids are the main
responsible of the bitterness of the beer, essential oils from the
hops are responsible for the bulk of the aroma and ﬂavour. Bit-
tering is applied by boiling hop a-acids, converting them to
iso-a acids, which are bitter. In particular, throughout the tra-
ditional wort-boiling process, the specialized metabolites are
converted into valuable compounds. Therefore, in the beer
there are bitter compounds that are not present in the hops
(Champagne and Boutry 2017). Isomerized a-acid can also be
added after fermentation. During fermentation, prenyl ﬂavo-
noids are lost due to incomplete hop extraction in must (13–
25%), absorption of insoluble must (18–26%) and adsorption
of yeast cells. After brewing beer, xanthohumol are largely in
the form of isoxanthohumol (about 22–30% of hop xanthohu-
mol); about 10% of desmethylxanthohumol is completely
transformed into prenyl naringenin; geranyl naringenin
behaves in a very similar way to the desmethylxanthohumol. In
addition, malt carbohydrates form soluble complexes with xan-
thohumol and isoxanthohumol (Stevens et al. 1999a). The iso-
xanthohumol is the most abundant ﬂavonoid in beer, ranging
from 0.04 to 3.44 mg/l (Stevens, Taylor, and Deinzer 1999b).
Hop-derived bitter compounds and glucose
metabolism: Current evidence
Current scientiﬁc evidence shows a direct effect of beer com-
pounds on glucose homeostasis (Huang, Wang, and Zhang
2017). In particular, it was found that in healthy men the mod-
erate daily consumption of beer (330 mL; 16 g alcohol), even
over a short period of use (30 d), induced signiﬁcant changes in
glucose homeostasis and lipid proﬁle, thereby reducing insulin
resistance (Nogueira et al. 2017). An in vivo study on murine
model showed that in type 2 diabetic KK-A(y) mice, the admin-
istration of xanthohumol decreased plasma levels of glucose,
triglyceride and weight of white adipose tissue, while increasing
levels of adiponectin, with an interesting effect in attenuating
diabetes (Nozawa 2005). This effect of xanthohumol on reduc-
tion of plasma glucose levels and weight was conﬁrmed in other
studies on rodent model of obesity, such as Zucker fa/fa rats
(Legette et al. 2013) or T2DM mice (Miranda et al. 2016), with
a clear dose-dependent effect. In addition, Miranda et al.
reported also a signiﬁcant decrease in triglycerides, total choles-
terol, Low Density Lipoprotein (LDL)-cholesterol, Interleukin
(IL)-6, Monocyte Chemoattractant Protein (MCP)-1, insulin
and leptin levels induced by xanthohumol administration, with
improvement of markers of systemic inﬂammation and meta-
bolic syndrome (Miranda et al. 2016). More recently, the effects
of xanthohumol were analyzed in association of 8-prenylnarin-
genin, another beer-derived polyphenol, on liver and skeletal
muscle lipid and glycolytic metabolism in T2DM mice model
(Costa et al. 2017). The Authors found that these polyphenols
promoted hepatic and skeletal muscle AMP-Activated Protein
Kinase (AMPK) activation, and reduced the expression of tar-
get lipogenic enzymes (sterol regulatory element binding pro-
tein-1c and fatty acid synthase) and acetyl-coenzyme A
carboxylase activity, thus preventing body weight gain and
improving plasma lipid proﬁle, insulin resistance and glucose
tolerance.
In vitro studies showed that these compounds are able to
activate Peroxisome Proliferator-Activated Receptors (PPAR)
a and PPARg, which modulate the transcription of genes
involved in regulation of glucose metabolism. PPARg agonists,
such as pioglitazone, indeed, are used to treat hyperglycemia or
T2DM. Several studies showed that isohumulones improved
glycemic and lipidemic metabolism, acting with a mechanism
similar to those of pioglitazone. Interestingly, unlike pioglita-
zone, isohumulone does not cause increased body weight. In
type 2 diabetic mice, isohumulones reduced blood levels of glu-
cose, triglyceride and free fatty acids. In subjects with mild
T2DM, isohumulones reduced not only plasma glucose and
Hemoglobin A1c (HbA1c), but also systolic blood pressure,
supporting its role as a natural agent for treatment of obesity,
diabetes and associated complications, such as hypertension
(Kondo 2004). A study in humans investigated the
Table 2. Bitter compounds present in beer (Kao and Wu 2013).
Bitter compound Mean content (mg/g)
Isoxanthohumol 36.2
Xanthohumol 29.6
8-prenylnaringenin 7.84
6-prenylnaringenin 19.2
Cohumulone 44.7
Humulone 123
Adhumulone 21.8
Colupulone 44.2
Lupulone 33.2
Adlupulone 5.76
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hypoglycemic effect of isohumulones in subjects with prediabe-
tes. Isomerized hop extract, containing note amounts of isohu-
mulones, was tested using soft capsule by Obara et al. (Obara
et al. 2009) In their study, 95 subjects with prediabetes, were
randomly assigned to each of the four study group: A (placebo),
B (16 mg of isohumulones), C (32 mg of isohumulones) and D
(48 mg of isohumulones); each treatment was followed for
12 weeks. Results showed that 48 mg isohumulones for
12 weeks were effective in decreasing fasting blood glucose,
HbA1c, body weight and abdominal fat, suggesting a possible
role for isohumulones a novel natural treatment for the man-
agement of obesity and T2DM (Obara et al. 2009). In addition,
Costa et al. focused on the effects exerted by beer-derived poly-
phenols on diabetic wound healing, reporting that antioxidant
and anti-inﬂammatory effects of xanthohumol supplemented
in beer were effective in modulating oxidative stress, inﬂamma-
tion and angiogenesis, three intermingled processes implicated
in the pathogenesis of diabetes mellitus and diabetic vascular
complications (Costa et al. 2013).
The hop-derived bitter acids also contribute to the overall
microbial stability of beer via favoring the brewer’s yeast over
other microorganisms (Champagne and Boutry 2017). Recent
evidence suggests the anti-inﬂammatory potential of hops-
derived compounds, which are exerted via the inhibition of
plasma lipopolysaccharide (LPS)–stimulated prostaglandin E2
production, nitric oxide formation, cyclooxygenase 2 abun-
dance, and the proinﬂammatory transcription factors Nuclear
Factor kappa B (NF-kB) pathway in macrophages (Desai et al.
2009). In particular, tetrahydroisoalpha acids, a well-deﬁned
hop extract (termed META060) derived from hops, has been
found to exert anti-inﬂammatory activity on LPS-stimulated
tumor necrosis factor alpha (TNF-a) and interleukin-6 (IL-6)
production in isolated peripheral blood mononuclear cells
(Konda et al. 2010). Everard et al. (Everard et al. 2012) analyzed
the effect of META060 on body weight gain, fat mass develop-
ment, glucose homeostasis and gut barrier function markers in
diet-induced obese and type 2 diabetic mice treated with
META060 for 8 weeks. In this study, the Authors reported that
META060 was effective in reducing body weight gain, adipo-
genesis, glucose intolerance, and fasted hyperinsulinemia, and
normalizing insulin sensitivity markers. Of interest, these
effects were associated with the improvement of gut barrier
function, with consequent reduced metabolic endotoxemia and
inﬂammation.
Besides the effects of speciﬁc hop-ﬂavored ﬂavonoids of the
beer, only few studies directly investigated the effect of the beer
on glucose metabolism. As reported by H€at€onen KA et al.
(H€at€onen et al. 2012) beer produced a high Glycemic Index
(GI) value, the numerical index that ranks carbohydrates
according to how they affect blood glucose levels (IOS 2010),
due to its content of complex maltooligosaccharides (H€at€onen
et al. 2012). However, Hosaka et al (Hosaka et al. 2008) evalu-
ated the effect of alcohol on blood glucose levels in T2DM
patients treated by diet alone, within 2 h after the respective
intake of three different alcoholic beverage: beer, sake (a fer-
mented alcoholic beverage) and shochu (a distilled alcoholic
beverage). Beverage used in this study, indeed, had a different
nutritional composition, in particular, relative to alcohol (beer:
3.7%; sake: 12.3%; shochu: 20.5%) and glucose (beer: 3.1%;
sake: 4.9%; shochu: 0%), while the amount of each beverage
was calculated to obtain an almost equal intake of ethanol. The
Authors found that, although a limited intake of alcoholic
drinks was required to improve blood glucose levels, beer con-
sumption caused the greatest increase in blood glucose levels
compared to other beverages due its higher carbohydrate con-
tents. Nevertheless, it should be considered that that the
amount of beer consumed in the study (800 ml) was higher
than the standard drink (330 ml), as described by USDA
(USDA 2017). Additionally, it has reported that the consump-
tion of non-alcoholic beer tended to lower the GI compared to
beer (H€at€onen et al. 2012). Taking in account these considera-
tions, it is not possible to conclude that beer consumption per
se worsens glucose homeostasis, but only that glucose content
of this beverage could be involved in this negative metabolic
mechanism. Among further possible mechanisms that improve
glucose metabolism through beer consumption, bitter taste
receptors stimulation by beer bitter compounds could play a
fundamental role.
Bitter taste receptors
Bitter taste is considered to be a toxicity detector, which pro-
vides a ﬁnal analytical detector just before ingestion, in a warn-
ing and defensive modality (Yan et al. 2001). Bitter is sensed by
25 subtypes of the Taste Receptor Type 2 (TAS2R or T2R) fam-
ily of with seven-transmembrane G protein-coupled receptors
expressed in the oral cavity (Lu et al. 2017). Recently, taste
receptors have been identiﬁed in extra-oral tissues, suggesting
additional functions for these receptors besides taste perception
(Chandrashekar et al. 2006). a-gustducin, a taste-speciﬁc G-
protein that detects sweetness, umami and bitterness, is a heter-
otrimeric protein composed of the products of the GNAT3
(a-subunit), GNB1 (b-subunit) and GNG13 (g-subunit)
(Wong, Gannon, and Margolskee 1996). After the binding of
bitter taste compounds to T2Rs on taste receptor-expressed
cells, T2R signal transduction starts with the dissociation of
a-gustducin into Ga and Gbg subunits. The Ga subunit stimu-
lates Phosphodiesterase (PDE) and then a decrease of the intra-
cellular cAMP level, while Gbg stimulates phospholipaseb2
(PLCb2) for activation of the IP3/DAG pathway, thereby lead-
ing to the release of calcium ions into the cytosol due to the
activation of the inositol trisphosphate receptor (InsP3R) in the
endoplasmic reticulum. The activation of the IP3/DAG path-
way is followed by the NaC inﬂux through the membrane cat-
ion channel Transient Receptor Potential M5 (TRPM5), which
depolarizes the cells and causes the release of gut hormones
from vesicles gastrointestinal tract and neurotransmitter ATP
through gap junction hemichannels (Park et al. 2015; Avau
et al. 2015; Lu et al. 2017). The subsequent cell depolarization
and neurotransmitter release activate sensory nerves cranial
nerves VII, IX, and X that project to the nucleus of the solitary
tract in the medulla (Katz, Nicolelis, and Simon 2000). The dis-
covery of taste receptors and their downstream signaling path-
ways in the endocrine cells of gastrointestinal tract suggests
that they might sense nutrients, similarly to the taste receptor
cells on the tongue, thereby contributing to the regulation of
gut motility and gut hormones release, which modulate hunger
signalling (Avau et al. 2015; Depoortere 2015; Andreozzi et al.
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2015; Avau and Depoortere 2016). Therefore, although a com-
plex set of signaling cascades modulates the release of gut hor-
mones, a therapeutic potential in the treatment of obesity and
T2DM of bitter agonists might be currently suggested (Avau
et al. 2015).
Effect of bitter compounds on Glucagon-like peptide 1
Taste receptors expressed on endocrine cells of gastrointestinal
tract could be involved in the modulation of the secretion of
gut hormones, mainly Glucagon-like Peptide 1 (GLP-1)
(Rozengurt et al. 2006). The endocrine cells of the gastrointesti-
nal tract represent <1% of the intestinal epithelium, but, as a
whole, they constitute the largest endocrine organ of the body,
producing and releasing >20 identiﬁed hormones (Rehfeld
1998). GLP-1 is a peptide-derived hormone belonging to the
incretin family, which is primarily produced by the cleavage of
the proglucagon in endocrine intestinal L cells (Campbell and
Drucker 2013). During fasting, in humans, this hormone is
present in a range of 5 to 10 pmol/L, while reaching two to
three times higher levels after meals. Its half-life is very short,
about 2 minutes, due to degradation by Dipeptidyl Peptidase
(DPP)-4. GLP-1 exists in two biologically active form: GLP-1-
(7–37) and GLP-1-(7–36)NH2 (Campbell and Drucker 2013).
This hormone is secreted in response to a variety of nutrients,
such as carbohydrates, ﬁbers, proteins, amino acids, Monoun-
saturated Fatty Acids (MUFA), Polyunsaturated Fatty Acid
(PUFA) and non-nutritional sweeteners. GLP-1 increases the
glucose-dependent insulin release by pancreatic b-cells and
suppresses the glucagon secretion. Speciﬁcally, when plasma
glucose levels are normal, GLP-1 is not able to stimulate insulin
secretion; in this way it does not cause hypoglycemia (Pham
et al. 2016). GLP-1 also confers glucose sensitivity to glucose-
resistant b cells, stimulates b cell proliferation, and inhibits b
cell apoptosis. Additionally, GLP-1 slows gastric emptying, pro-
motes satiety and suppresses energy intake (Steinert, Beglinger,
and Langhans 2016; Zanchi et al. 2017). As a representative
incretin, GLP-1 is currently one of the most important target
for the treatment of T2DM (Troke, Tan, and Bloom 2014).
Nevertheless, increasing endogenous GLP-1 secretion as a ther-
apeutic strategy has led to heightened interest in endocrine cells
of gastrointestinal tract and the gut-pancreatic axis (Ezcurra
et al. 2013). In particular, the activation of T2R has been stud-
ied as a potential therapeutic target of T2DM because of its
stimulation of GLP-1 resulting in hypoglycemic effect (Depoor-
tere 2014).
The effects of T1R on GLP-1 secretion have been previously
reported, and L cells of the gut are able to “taste” glucose
through the same mechanisms used by taste cells of the tongue
(Jang et al. 2007). Interestingly, it was also observed that T2R
haplotype is associated with impaired glucose homeostasis, as a
Single Nucleotide Polymorphisms (SNPs) in this haplotype
alter the normal T2R9 receptor response, resulting in an
impairment of glucose homeostasis (Dotson et al. 2008; Shin
et al. 2008). In the recent years, remarkable progress has been
made in demonstrating the expression of molecular transducers
in bitter taste signaling of cells in the gastrointestinal tract
involved in the secretion of gut hormones (Li et al. 2017). In
particular, induced increase in GLP-1 by bitter compounds has
been considered to have an important role in host defence
through reduction of toxic food intake (Kim, Egan, and Jang
2014). Several in vitro studies showed that the interaction of
various bitter compounds with T2R on human and murine
endocrine cells of gastrointestinal tract determines the secretion
of gut hormones. The scientiﬁc evidence is summarized in
Table 3. In details, Rozengurt et al. reported that the stimula-
tion of both human colon and intestinal endocrine cell lines
(HuTu-80 and NCI-H716 cells expressing GLP-1) with the bit-
ter-tasting compound phenylthiocarbamide, which binds
T2R38 induced a rapid increase in the intracellular Ca2C con-
centration in these cells (Rozengurt et al. 2006). Additionally,
the administration of denatonium benzoate, a ligand of bitter
taste receptor cells, in diabetic mice (Lepr¡/¡ (db/db) mice)
resulted in decreased blood glucose levels and increased GLP-1
levels compared with the control group (Kim, Egan, and Jang
2014). On the other hands, as previously mentioned, Avau
et al. demonstrated that the administration of denatonium ben-
zoate resulted in a reduced gastric emptying on mice and
increased satiation in humans (Avau et al. 2015). More
recently, Park J et al. found that GLP-1 hormone is co-localized
with T2R5 in the human duodenum and ileum tissue and that
1,10-phenanthroline, which is known agonist of T2R5, is able
Table 3. Main studies demonstrating effect of bitter substances on glucagon-like peptide-1 secretion.
Authors Type of study Bitter substance Cell line/experimental model Receptor
Main experimental
method
Rozengurt et al. 2006 In vitro Phenylthiocarbamide HuTu80 NCIH716 T2R38 RT-PCR
Kim, Egan, and Jang
2014
In vitro and in vivo Denatonium benzoate NCIH716 Lepr¡/¡ (db/db) mice T2R RT-PCR Small interfering
(si)RNA preparation
Park et al. 2015 In vitro 1,10-phenanthroline Human L cells T2R5 RT-PCR
Yu et al. 2015 In vitro Berberine NCIH716 T2R38 Western blot
chemiluminescence
assay
Pham et al. 2016 In vitro and in vivo Propylthiouracil Knockout HuTu-80 old
male BALB/c mice
T2R38 Small interfering (si)RNA
preparation IHC
Li et al. 2017 In vitro and in vivo Qing-Hua Granule db/db diabetic mice TS2R /TS2R5
a-gustducin PLCb2
TRPM5
RT-PCR, Western blot
IHC
T2R: Taste Receptor Type 2; GLP-1: Glucagon-like Peptide-1; RT-PCR: Real-time Polymerase Chain Reaction; T2R5: Taste Receptor Type 2 Member 5; T2R38: Taste Receptor
Type 2 Member 38; IHC: Immunohistochemistry; PLCb2: 1-phosphatidylinositol-4: 5-bisphosphate phosphodiesterase b-2; TRPM5: Transient Receptor Potential Cation
Channel Subfamily Member 5.
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to secrete GLP-1 hormone through stimulation of T2R5 in
human endocrine cells of gastrointestinal tract (Park et al.
2015). Berberine, the main component of a number of particu-
larly bitter medicinal plants, including Coptis Rhizome, has
been successfully used for T2DM (Yu et al. 2015; Chang, Chen,
and Hatch 2015). In previous studies, berberine-induced GLP-
1 secretion has reported as a possible mechanism for berberine
hypoglycemic effect (Yu et al. 2010; Lu et al. 2009; Yu et al.
2015). Yu Y et al. demonstrated that berberine stimulated the
GLP-1 secretion via activation of gut-expressed bitter taste
receptors through the PLCb2 signaling cascades in human
enteroendocrine NCI-H716 cells, but not TRPM5 (Yu et al.
2015). Recent studies revealed that also Qing-Hua Granule, a
compound originated from Gegen-Qinlian-Decoction, one of
the well-known traditional Chinese medicines clinically
employed also to treat T2 diabetic patients, regulated glucose
homeostasis by inducing GLP-1 secretion via activation of
T2R5 expressed in gastrointestinal tract in db/db diabetic mice
(Li et al. 2017). Additionally, agonists of T2R38, such as the bit-
ter compound 6-n-propylthiouracil, are able to increased GLP-
1 levels and have suggested as novel and effective agents in dia-
betes management (Pham et al. 2016).
Taking in account the nutrition composition of beer and, in
particular, its amount of bitter compounds, it is tempting to
speculate that just these nutrients would be involved in the acti-
vation of GLP-1 pathway, thereby contributing to beer hypo-
glycemic effects. Nevertheless, other beer compounds might
offer a further explanation for the favorable effects of beer con-
sumption on glucose homeostasis. Indeed, besides the possible
effects on GLP-1 secretion of beer carbohydrates, mainly malt
oligosaccharides and starch, interestingly polyphenols from
various sources have proven to stimulate L-cells to secrete
GLP-1 (Domınguez Avila et al. 2017). However, in the previous
literature it has been hypothesized that the main effects of poly-
phenols on GLP-1 secretion is due to different mechanisms,
including the increase in its half-life by inhibiting DPP4, the
stimulation of b-cells to secrete insulin and stimulate the
peripheral response to insulin, increasing the overall effects of
the GLP1-insulin axis, but it was not yet hypothesized that this
happens through the stimulation of the bitter receptors. Addi-
tionally, alcohol per se has also been shown to inﬂuence a num-
ber of hormones linked to satiety, including GLP-1 (Traversy
and Chaput 2015).
Conclusion and future prospectives
The discovery of a new pathway for the secretion by L-intesti-
nal cells of the GLP-1 following the presence of macronutrients
in the intestine, has led to the research for incretins as a new
class of antidiabetic drugs. Increasing endogenous GLP-1 secre-
tion as a therapeutic strategy has led to heightened interest in
nutrient-sensing mechanisms and endocrine cells of gastroin-
testinal tract. Recent evidence indicated that a number of bitter
compounds interact with receptors belonging to the T2R family
expressed on human and murine enteroendocrine cell mem-
brane and are able to stimulate the release of different gut hor-
mones, mainly GLP-1, which is strictly involved in glucose
metabolism. Therefore, it tempting to speculate that also bitter
compounds in the beer, when introduced in small amounts
with carbohydrates (which instead stimulate the sweet taste),
could favor the metabolism of carbohydrates by stimulating
insulin secretion through gut hormone pathways, with a possi-
ble novel mechanism showed in Figure 1.
The main limitation in the use of hop-derived bitter
compounds in clinical practice is that they are contained in
beer whose excessive consumption could result in several
adverse health effects due to both alcohol and the high con-
tent of glucose. Thus, in view of the current evidence we
hypothesize that could be a novel possible mechanism
through which the beer may regulate glucose metabolism,
due to its bitter components, thereby suggesting a nutraceu-
tical approach using bitter molecules from beer in a phar-
maceutical formulation, such as acid-resistant capsules in
order to avoid the side effects related to excessive consump-
tion of beer. Nevertheless, it should be considered that beer
is a mix of different ingredients, such as polyphenols, which
exert their function in a synergistic manner. Future studies
are mandatory to investigate whether the possible contribu-
tion of different beer bitter compounds to the favorable
effects exerted by beer on glucose homeostasis is also medi-
ated by the stimulation of the secretion gut hormones. In
the same way, it could be possible investigate if consump-
tion of dealcoholized beer could improve glucose homeosta-
sis making the bitter compounds of beers a promising
strategy for management diabetic patients.
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Figure 1. Suggested mechanism of action of beer bitter compounds on glucose
homeostasis. Legend: The possible mechanism of action by which bitter com-
pounds contained in beer could regulate glucose metabolism involves the stimula-
tion of bitter Taste Receptors (T2R) activity. Brieﬂy, similarly to other bitter
compounds, beer bitter compounds could interact with T2R expressed in gastroin-
testinal tract, resulting in the stimulation of gut hormone secretion, in particular,
Glucagon-like peptide 1 (GLP-1), Cholecystokinin (CCK), Peptide YY (PYY), involved
in glucose homeostasis.
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